by Matt Foor | Jan 23, 2012
Check out this article by Nick Taylor from in-pharmatechnologist.com. This article shares how FDA plans to study foreign regulators’ GMP reports to assist with enforcement efforts. The study will take place from 2013 to 2017 which is the duration of the first...
by Matt Foor | Jan 20, 2012
A recent survey of Biomedical company CEOs completed by the CHI-California Healthcare Institute, BayBio, and PWC in the US showed that access to capital, a burdensome and uncertain regulatory environment, and lack of innovation and productivity in research and...